In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis

• Príomhchruthaitheoirí: Dahara Keyse Carvalho Silva (Údar), Jessicada Silva Teixeira (Údar), Diogo Rodrigo Magalhães Moreira (Údar), Tiago Fernandes da Silva (Údar), Eliezer Jesus de Lacerda Barreiro (Údar), Humberto Fonseca de Freitas (Údar), Samuel Silva da Rocha Pita (Údar), André Lacerda Braga Teles (Údar), Elisalva Teixeira Guimarães (Údar), Milena Botelho Pereira Soares (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Leishmaniasis are group of neglected diseases with worldwide distribution that affect about 12 million people. The current treatment is limited and may cause severe adverse effects, and thus, the search for new drugs more effective and less toxic is relevant. We have previously investigated the immu...